Glenview State Bank Trust Department’s Inovio Pharmaceuticals INO Stock Holding History

Glenview State Bank Trust Department’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-833	Closed	-$33K	–	104
2019 Q4	$33K	Hold	833	–	–	0.01%	112
2019 Q3	$21K	Hold	833	–	–	0.01%	113
2019 Q2	$29K	Hold	833	–	–	0.01%	109
2019 Q1	$37K	Hold	833	–	–	0.02%	107
2018 Q4	$40K	Hold	833	–	–	0.02%	99
2018 Q3	$56K	Hold	833	–	–	0.02%	98
2018 Q2	$39K	Hold	833	–	–	0.02%	98
2018 Q1	$47K	Hold	833	–	–	0.02%	96
2017 Q4	$41K	Hold	833	–	–	0.02%	99
2017 Q3	$63K	Buy	+833	New	+$62K	0.03%	95
2017 Q2	–	Sell	-833	Closed	-$66K	–	94
2017 Q1	$66K	Buy	+833	New	+$66.4K	0.03%	94

Other funds holding INO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Glenview State Bank Trust Department's INO Position: Q1 2020 in Review

Glenview State Bank Trust Department sold out of Inovio Pharmaceuticals (INO) in Q1 2020, closing a stake of 833 shares — an estimated $33K sold.

Glenview State Bank Trust Department first reported a position in INO in Q1 2017 and held it in 11 quarters. The position peaked at $66K in Q1 2017. 158 funds tracked by Wall St. Rank hold INO as of Q1 2020.

Glenview State Bank Trust Department reported no remaining Inovio Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Glenview State Bank Trust Department sold 833 Inovio Pharmaceuticals shares in Q1 2020, an estimated $33K.
Glenview State Bank Trust Department first reported a position in Inovio Pharmaceuticals in Q1 2017 and held it in 11 quarters.
Glenview State Bank Trust Department's Inovio Pharmaceuticals position peaked at $66K in Q1 2017.
158 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2020.

Based on Glenview State Bank Trust Department's 13F filing for Q1 2020, filed 1 May 2020.